血漿組織蛋白酶和炎癥因子含量與腹主動(dòng)脈瘤危險(xiǎn)度關(guān)系的研究
本文選題:組織蛋白酶L + 組織蛋白酶K ; 參考:《華中科技大學(xué)》2016年博士論文
【摘要】:第一部分血漿組織蛋白酶L、K和V含量與腹主動(dòng)脈瘤危險(xiǎn)度關(guān)系目的組織蛋白酶L (CatL)、組織蛋白酶K (CatK)以及組織蛋白酶V (CatV)作為潛在的彈性蛋白酶參與人動(dòng)脈壁重塑。本文的目的是觀測(cè)在腹主動(dòng)脈瘤(AAA)患者的血漿中這些組織蛋白酶是否發(fā)生改變。方法476名男性AAA患者作為實(shí)驗(yàn)組,200名年齡匹配的男性作為對(duì)照組。取血漿并用ELISA檢測(cè)CatL、CatK和CatV的濃度。t檢驗(yàn)、ROC曲線明確實(shí)驗(yàn)組和對(duì)照組之間是否存在差異。皮爾森相關(guān)分析檢驗(yàn)CatL與AAA疾病相關(guān)危險(xiǎn)因素之間的關(guān)系。邏輯回歸分析驗(yàn)證血清學(xué)指標(biāo)是否能作為疾病的獨(dú)立預(yù)測(cè)指標(biāo)。結(jié)果t檢驗(yàn)發(fā)現(xiàn)AAA病人血漿中CatL的含量高于對(duì)照組人群(p0.0001),而CatK和CatV含量在AAA病人中降低(P=0.052, P=0.025). ROC曲線分析再次證實(shí)了CatL的含量在AAA病人血漿中表達(dá)增高具有統(tǒng)計(jì)學(xué)意義(p0.001)。在潛在的混雜性因素中,吸煙、血管緊張素轉(zhuǎn)化酶(ACE)抑制劑、阿司匹林、氯吡格雷和他汀的使用與血漿CatL含量密切相關(guān)。皮爾森相關(guān)分析指出血漿CatL與組織蛋白酶S (CatS)(r=0.43,P0.0001)、體重指數(shù)(BMI)(r=0.07,P=0.047)以及最大動(dòng)脈直徑(r=0.29,P0.001)呈正比例增加;而與最低踩臂指數(shù)(ABI)呈負(fù)相關(guān)(r=0.22,p0.001)。用偏相關(guān)分析對(duì)上述可能的混雜因素進(jìn)行校正后,血漿CatL與CatS (r=0.43,P0.0001)、最大動(dòng)脈直徑(r=0.212,P0.001)仍具有正相關(guān),與最低ABI呈負(fù)相關(guān)(r=0.10,P=0.011)。多元邏輯回歸分析提示在對(duì)上述相同的混雜因素進(jìn)行校正前后(優(yōu)勢(shì)比(OR)分別為OR=3.04, P0.001、OR=2.42, p0.001)均提示血漿CatL為AAA的危險(xiǎn)因子。結(jié)論血漿中CatL的含量與動(dòng)脈直徑大小、最低踝臂指數(shù)(ABI)的相關(guān)性提示這種半胱氨酸蛋白酶在人外周動(dòng)脈疾病和AAA中發(fā)揮重要作用。第二部分血漿炎癥因子含量與腹主動(dòng)脈瘤危險(xiǎn)度關(guān)系目的AAA斑塊中有大量的炎癥細(xì)胞浸潤(rùn),以分泌炎性因子并促進(jìn)動(dòng)脈瘤進(jìn)展為特征。本文的目的是檢測(cè)外周血細(xì)胞因子的含量是否能夠預(yù)測(cè)AAA的危險(xiǎn)程度。方法476名男性AAA患者作為實(shí)驗(yàn)組,200名年齡匹配的男性作為對(duì)照組。取血漿并用ELISA檢測(cè)白介素6(IL-6)、白介素10(IL-10)、白介素17A (IL-17A)、Y干擾素(IFN-Y)和C反應(yīng)蛋白(CRP)的濃度。結(jié)果AAA病人血漿中IL-6、IFN-γ、IL-10和IL-17A含量較對(duì)照組低,而CRP含量高于對(duì)照組。IL-10的濃度與IFN-γ、IL-17A、IL-6呈正比,但與CRP無(wú)關(guān);此外,IL-10的濃度與收縮壓呈負(fù)相關(guān),而CRP與舒張壓、體重指數(shù)(BMI)呈正比。CRP是AAA的獨(dú)立危險(xiǎn)因子并與動(dòng)脈直徑呈正相關(guān)。IFN-γ、IL-17A和CRP與AAA橫截面積呈正相關(guān)。IL-10與AAA生長(zhǎng)速率呈正相關(guān)。AAA病人外周血CRP高于均數(shù)時(shí)動(dòng)脈瘤死亡的危險(xiǎn)性會(huì)增加。結(jié)論AAA病人中IFN-γ、IL-10、IL-17A含量減少,IFN-γ和IL-17A與AAA橫截面積呈正相關(guān),IL-10與AAA生長(zhǎng)速率、IFN-γ、IL-17A呈正相關(guān),提示Th1、Th2和Th17細(xì)胞免疫反應(yīng)參與了人AAA發(fā)病機(jī)制。
[Abstract]:Part I relationship between plasma cathepsin K and V levels and risk of abdominal aortic aneurysm objective cathepsin L, cathepsin K (Catk) and cathepsin V (Catv) are potential participants in arterial wall remodeling. The aim of this study was to observe the changes of these cathepsin in plasma of patients with abdominal aortic aneurysm (AAA). Methods 476 male patients with AAA were used as control group of 200 age matched males in the experimental group. The plasma levels of CatLK and CatV were measured by ELISA. T test was used to determine whether there was a difference between the experimental group and the control group. Pearson correlation analysis examined the relationship between CatL and risk factors associated with AAA disease. The logistic regression analysis verifies whether the serological index can be used as an independent predictor of disease. Results t test showed that the content of CatL in plasma of AAA patients was higher than that of control group (P 0.0001), while the contents of CatK and CatV in AAA patients were decreased by 0.052 and 0.025% respectively. ROC curve analysis confirmed that the increase of CatL expression in plasma of AAA patients was statistically significant (P 0.001). Among the potential confounding factors smoking angiotensin-converting enzyme (ACE) inhibitors aspirin clopidogrel and statins were associated with plasma CatL levels. Pearson correlation analysis showed that plasma CatL was increased in proportion to cathepsin S (cat) 0.43 (P 0.0001), body mass index (BMI) 0.07 ~ (0. 047) and maximum arterial diameter (r ~ (0.29) P ~ (0.001), but negatively correlated with minimum arm index (n = 0.22), P ~ (0.001). After correction of the above possible confounding factors by partial correlation analysis, the plasma CatL was positively correlated with CatS 0.43 (P 0.0001), and the largest artery diameter was 0.212g / P 0.001), and negatively correlated with the lowest ABI, and negatively correlated with the lowest ABI. Multiple logistic regression analysis showed that plasma CatL was a risk factor for AAA before and after correction (odds ratio: OR3.04, P0.001OR2.42, p0.001). Conclusion the correlation between plasma CatL content and arterial diameter and minimum malleolus brachial index (ABI) suggests that cysteine protease plays an important role in human peripheral artery disease and AAA. The relationship between plasma inflammatory factor content and risk of abdominal aortic aneurysm objective A large number of inflammatory cells infiltrate in AAA plaque characterized by secretion of inflammatory factors and promotion of aneurysm progression. The aim of this study was to determine whether the level of cytokines in peripheral blood could predict the risk of AAA. Methods 476 male patients with AAA were used as control group of 200 age matched males in the experimental group. The concentrations of interleukin 6 (IL 6), interleukin 10 (IL 10), Interleukin-17A (IL 17 A), interferon Y (IFN-Y) and C reactive protein (CRP) were determined by ELISA. Results the levels of IL-10 and IL-17A in plasma of patients with AAA were lower than those of the control group, while the concentration of CRP was higher than that of the control group. The concentration of IL-10 was directly proportional to the concentration of IL-17A4 IL-6, but not related to CRP. In addition, the concentration of IL-10 was negatively correlated with systolic blood pressure, while that of CRP was negatively correlated with diastolic blood pressure. BMI-CRP was an independent risk factor for AAA and positively correlated with arterial diameter. IL-17A and CRP were positively correlated with AAA cross-sectional area. IL-10 was positively correlated with AAA growth rate. The risk of aneurysm death was increased when CRP in peripheral blood was higher than the mean in patients with AAA. Conclusion there is a positive correlation between IL-10 and AAA cross sectional area in patients with AAA. There is a positive correlation between IL-10 and AAA growth rate and IL-17A, which suggests that Th1Th _ 2 and Th17 cell immune reaction may play an important role in the pathogenesis of human AAA.
【學(xué)位授予單位】:華中科技大學(xué)
【學(xué)位級(jí)別】:博士
【學(xué)位授予年份】:2016
【分類號(hào)】:R543.16
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 許鎖春,耿希剛,王海晨,劉建林;腹主動(dòng)脈瘤外科治療1例報(bào)告[J];西安醫(yī)科大學(xué)學(xué)報(bào);2002年01期
2 張強(qiáng);炎性腹主動(dòng)脈瘤的診斷及外科治療[J];中國(guó)實(shí)用外科雜志;2002年03期
3 田成武,朱華文,曲明,姜田軍,張衛(wèi)國(guó),杜英東;腹主動(dòng)脈瘤13例臨床分析[J];臨床軍醫(yī)雜志;2002年01期
4 田成武,朱華文,曲明,姜田軍,張衛(wèi)國(guó),杜英東;腹主動(dòng)脈瘤破裂大出血救治成功1例[J];實(shí)用醫(yī)藥雜志;2002年10期
5 肖康雅;巨大腹主動(dòng)脈瘤破裂1例[J];中華超聲影像學(xué)雜志;2002年08期
6 潘要干;腹主動(dòng)脈瘤腔內(nèi)修補(bǔ)后的監(jiān)控[J];中國(guó)介入心臟病學(xué)雜志;2002年01期
7 連福珍;腹主動(dòng)脈瘤10例診治體會(huì)[J];廣東醫(yī)學(xué);2003年02期
8 劉威,張克政;腹主動(dòng)脈瘤的診斷與外科治療[J];實(shí)用診斷與治療雜志;2003年05期
9 楊培紅,白峰;腹主動(dòng)脈瘤破裂1例[J];罕少疾病雜志;2003年06期
10 徐斌,周穎奇,何天霖,梅舉,許華,錢寶華,曹貴松,景在平;多學(xué)科聯(lián)合治療破裂性腹主動(dòng)脈瘤[J];中華急診醫(yī)學(xué)雜志;2003年08期
相關(guān)會(huì)議論文 前10條
1 潘松齡;;腹主動(dòng)脈瘤若干問(wèn)題探討[A];浙江省中西醫(yī)結(jié)合學(xué)會(huì)周圍血管疾病專業(yè)委員會(huì)第一次學(xué)術(shù)年會(huì)暨省級(jí)繼續(xù)教育學(xué)習(xí)班資料匯編[C];2005年
2 秋陽(yáng);李治安;孫琳;孟冷;;超聲診斷腹主動(dòng)脈瘤破裂的臨床應(yīng)用研究[A];中華醫(yī)學(xué)會(huì)第十次全國(guó)超聲醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2009年
3 賴梅芳;范文丹;;彩超對(duì)腹主動(dòng)脈瘤的診斷價(jià)值[A];中國(guó)超聲醫(yī)學(xué)工程學(xué)會(huì)第八屆全國(guó)腹部超聲學(xué)術(shù)會(huì)議論文匯編[C];2010年
4 張生奕;;腹主動(dòng)脈瘤破裂1例報(bào)告[A];中華醫(yī)學(xué)會(huì)急診醫(yī)學(xué)分會(huì)第十三次全國(guó)急診醫(yī)學(xué)學(xué)術(shù)年會(huì)大會(huì)論文集[C];2010年
5 楊顯紅;;腹主動(dòng)脈瘤病人的健康教育[A];全國(guó)神經(jīng)內(nèi)外科?谱o(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2004年
6 ;腹主動(dòng)脈瘤的診斷與急救處理[A];第十一次全國(guó)急診醫(yī)學(xué)學(xué)術(shù)會(huì)議暨中華醫(yī)學(xué)會(huì)急診醫(yī)學(xué)分會(huì)成立二十周年慶典論文匯編[C];2006年
7 汪翠萍;李志娟;李紅光;;手術(shù)治療腹主動(dòng)脈瘤36例護(hù)理體會(huì)[A];全國(guó)外科護(hù)理學(xué)術(shù)交流暨專題講座會(huì)議論文匯編[C];2008年
8 馬旭;呂忠;程云霄;;腎下腹主動(dòng)脈瘤外科治療[A];2008年浙江省血管外科年會(huì)論文匯編[C];2008年
9 陳花;;腹主動(dòng)脈瘤的超聲研究進(jìn)展[A];中國(guó)超聲醫(yī)學(xué)工程學(xué)會(huì)第九屆全國(guó)腹部超聲醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2012年
10 郝滬明;;腹主動(dòng)脈瘤膜支架放置術(shù)后的彩超隨訪掃查[A];中國(guó)超聲醫(yī)學(xué)工程學(xué)會(huì)第九屆全國(guó)腹部超聲醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2012年
相關(guān)重要報(bào)紙文章 前10條
1 吳美華;對(duì)腹主動(dòng)脈瘤應(yīng)積極進(jìn)行藥物治療[N];中國(guó)醫(yī)藥報(bào);2008年
2 北京協(xié)和醫(yī)院血管外科中心 劉昌偉邋陳躍鑫;腹主動(dòng)脈瘤 難辨的兇手[N];健康報(bào);2008年
3 程懷孟;直徑小于5厘米腹主動(dòng)脈瘤可保守治療[N];衛(wèi)生與生活報(bào);2009年
4 記者 朱國(guó)旺;腹主動(dòng)脈瘤一旦發(fā)現(xiàn)應(yīng)立即治療[N];中國(guó)醫(yī)藥報(bào);2010年
5 程智;兇險(xiǎn)的腹主動(dòng)脈瘤[N];大眾衛(wèi)生報(bào);2004年
6 本報(bào)記者 張磊;80%腹主動(dòng)脈瘤患者為男性[N];健康報(bào);2013年
7 陳祖亮邋記者 胡德榮;巨大腹主動(dòng)脈瘤破裂患者獲救[N];健康報(bào);2007年
8 上海長(zhǎng)海醫(yī)院血管外科 張雷邋景在平;腹主動(dòng)脈瘤需手術(shù)[N];健康報(bào);2007年
9 上海交通大學(xué)醫(yī)學(xué)院附屬第九人民醫(yī)院血管外科主任醫(yī)師 黃新天;人體“定時(shí)炸彈”——腹主動(dòng)脈瘤[N];上?萍紙(bào);2008年
10 健康時(shí)報(bào)記者 趙晴晴;血管超聲查腹主動(dòng)脈瘤[N];健康時(shí)報(bào);2010年
相關(guān)博士學(xué)位論文 前10條
1 左尚維;細(xì)胞外基質(zhì)降解通路相關(guān)基因多態(tài)性和血清MMP-2蛋白水平與腹主動(dòng)脈瘤的關(guān)聯(lián)[D];中國(guó)人民解放軍醫(yī)學(xué)院;2015年
2 劉琮琳;哮喘在人和小鼠腹主動(dòng)脈瘤發(fā)病中的作用及機(jī)制研究[D];鄭州大學(xué);2016年
3 聶皓;趨化因子受體CXCR2促進(jìn)腹主動(dòng)脈瘤發(fā)生的作用機(jī)制研究及血管生成素相關(guān)生長(zhǎng)因子在腹主動(dòng)脈瘤血漿中的變化[D];北京協(xié)和醫(yī)學(xué)院;2016年
4 張超;細(xì)胞外基質(zhì)蛋白CCN3抑制腹主動(dòng)脈瘤發(fā)生發(fā)展的機(jī)制研究[D];華中科技大學(xué);2015年
5 呂冰潔;血漿組織蛋白酶和炎癥因子含量與腹主動(dòng)脈瘤危險(xiǎn)度關(guān)系的研究[D];華中科技大學(xué);2016年
6 辛群;超聲技術(shù)在腹主動(dòng)脈瘤瘤壁運(yùn)動(dòng)和組織特性研究中的應(yīng)用[D];第二軍醫(yī)大學(xué);2008年
7 符洋;貝納普利抑制家兔腎下腹主動(dòng)脈瘤形成的研究[D];中南大學(xué);2009年
8 馮翔;細(xì)胞外基質(zhì)代謝在腹主動(dòng)脈瘤發(fā)病中的作用[D];第二軍醫(yī)大學(xué);2001年
9 熊江;壁應(yīng)力分布個(gè)體化預(yù)測(cè)腹主動(dòng)脈瘤破裂的初步研究[D];第二軍醫(yī)大學(xué);2005年
10 吳曉飛;雌激素在腹主動(dòng)脈瘤形成中的作用[D];中國(guó)醫(yī)科大學(xué);2007年
相關(guān)碩士學(xué)位論文 前10條
1 王建國(guó);影響腹主動(dòng)脈瘤延展及預(yù)后相關(guān)因素的臨床研究[D];中國(guó)人民解放軍醫(yī)學(xué)院;2012年
2 吳s,
本文編號(hào):1835082
本文鏈接:http://sikaile.net/yixuelunwen/xxg/1835082.html